Maharashtra FDA seizes stock of spurious Favimax worth Rs 1 54 cr

Nagpur | Friday | 4th June, 2021

Summary:

Maharashtra FDA seizes stock of spurious Favimax worth Rs 1.54 crBy Rajendra Diwe :The Government analyst declares samples of brand of Hcq 200 manufactured by non-existing Max Relief Healthcare as SpuriousMaharashtra FDA seized a stock of Rs 1.54 crore of spurious Favimax 400 and 200 mg from the stock points. Meanwhile the analytical report of samples of Hydroxychloroquine Sulphate tablets (M HCQ 200) manufactured by Max Relief Healthcare too has confirmed it as spurious. D R Gahane Joint Commissioner FDA Maharashtra (HQ Mumbai) told 'The Hitavada' “The Mumbai Police had arrested the alleged kingpin identified as Sudip Mukherji who ran Max Relief Healthcare. Thousands of strips of Favimax have been sold from major stockists in Aurangabad city in Maharashtra as well as district. Each strip of 10 tablets costs Rs 1290 and on the basis of this value FDA seized a stock of Rs 1.54 crore..